New search Hide text from Guidelines
N NERVOUS SYSTEMN04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
| The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease. No separate DDDs are established for oral depot formulations. |
N04A ANTICHOLINERGIC AGENTS
N04B DOPAMINERGIC AGENTS
N04C OTHER ANTIPARKINSON DRUGS
Last updated: 2024-01-26